IVAN ROSAS to Rituximab
This is a "connection" page, showing publications IVAN ROSAS has written about Rituximab.
Connection Strength
0.185
-
Rituximab in the Treatment of Interstitial Lung Disease Associated with Antisynthetase Syndrome: A Multicenter Retrospective Case Review. J Rheumatol. 2018 06; 45(6):841-850.
Score: 0.134
-
Design of the STRIVE-IPF trial- study of therapeutic plasma exchange, rituximab, and intravenous immunoglobulin for acute exacerbations of idiopathic pulmonary fibrosis. BMC Pulm Med. 2024 Mar 20; 24(1):143.
Score: 0.051